Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Granules India has signed a joint venture agreement with a Belgium-based pharma company Ajinomoto OmniChem to establish a bulk drugs and intermediaries manufacturing plant in Visakhapatnam, India with $20m investment.
Subscribe to our email newsletter
The joint venture, which is a 50-50 partnership deal, is expected to provide active pharmaceutical ingredients (API) to various other pharmaceutical firms.
With this manufacturing plant, the companies are expected to offer drugs related to oncology, central nervous system (CNS) cardio vascular diseases (CVD) and will be able to handle 4-6 products at a time.